Advancing new drug therapies for unmet medical needs

Developing novel drug therapies for unmet medical needs 2018-02-05T09:26:29+00:00

Dimerix Limited is a clinical stage biotechnology company that is listed on the Australian Stock Exchange (ASX:DXB)

Our vision is to positively improve human health by creating safe and effective new treatments for patients with unmet medical needs

Recent news and media

Media Coverage: Dr Boreham’s Crucible

In August, Dimerix was reviewed by reporter, Tim Boreham for Biotech Daily’s Dr Boreham’s Crucible column. To view a copy of [...]

ASX: BioShares Queenstown presentation

On 27 July 2018 at the BioShares Summit (Queenstown, New Zealand), Dimerix Chief Medical Officer Dr David Packham presented a a [...]

Dimerix a Winner of Westpac’s Businesses of Tomorrow Program

Dimerix is incredibly proud to have been named as a 2018 winner of the Westpac 200 Businesses of Tomorrow program in The [...]

Click here to view analyst coverage
Click here to view our corporate fact sheet
Click here to view our corporate presentation